vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $334.0M, roughly 1.1× WYNDHAM HOTELS & RESORTS, INC.). AdvanSix Inc. runs the higher net margin — -0.8% vs -18.0%, a 17.2% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -76.3%). WYNDHAM HOTELS & RESORTS, INC. produced more free cash flow last quarter ($168.0M vs $36.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -4.6%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
ASIX vs WH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $334.0M |
| Net Profit | $-2.8M | $-60.0M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | — |
| Net Margin | -0.8% | -18.0% |
| Revenue YoY | 9.4% | -76.3% |
| Net Profit YoY | -892.9% | -170.6% |
| EPS (diluted) | $-0.11 | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | $359.9M | $334.0M | ||
| Q3 25 | $374.5M | $382.0M | ||
| Q2 25 | $410.0M | $397.0M | ||
| Q1 25 | $377.8M | $316.0M | ||
| Q4 24 | $329.1M | $336.0M | ||
| Q3 24 | $398.2M | $396.0M | ||
| Q2 24 | $453.5M | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | $-2.8M | $-60.0M | ||
| Q3 25 | $-2.6M | $105.0M | ||
| Q2 25 | $31.4M | $87.0M | ||
| Q1 25 | $23.3M | $61.0M | ||
| Q4 24 | $352.0K | $85.0M | ||
| Q3 24 | $22.3M | $102.0M | ||
| Q2 24 | $38.9M | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | -11.4% | ||
| Q3 25 | -0.9% | 46.6% | ||
| Q2 25 | 7.7% | 37.8% | ||
| Q1 25 | 7.7% | 35.4% | ||
| Q4 24 | -3.9% | 38.4% | ||
| Q3 24 | 7.5% | 43.2% | ||
| Q2 24 | 11.5% | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | -0.8% | -18.0% | ||
| Q3 25 | -0.7% | 27.5% | ||
| Q2 25 | 7.7% | 21.9% | ||
| Q1 25 | 6.2% | 19.3% | ||
| Q4 24 | 0.1% | 25.3% | ||
| Q3 24 | 5.6% | 25.8% | ||
| Q2 24 | 8.6% | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | $-0.11 | $-0.77 | ||
| Q3 25 | $-0.10 | $1.36 | ||
| Q2 25 | $1.15 | $1.13 | ||
| Q1 25 | $0.86 | $0.78 | ||
| Q4 24 | $0.02 | $1.06 | ||
| Q3 24 | $0.82 | $1.29 | ||
| Q2 24 | $1.43 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $64.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $468.0M |
| Total Assets | $1.7B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | $19.8M | $64.0M | ||
| Q3 25 | $23.7M | $70.0M | ||
| Q2 25 | $18.4M | $50.0M | ||
| Q1 25 | $8.3M | $48.0M | ||
| Q4 24 | $19.6M | $103.0M | ||
| Q3 24 | $17.3M | $72.0M | ||
| Q2 24 | $12.1M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | $815.2M | $468.0M | ||
| Q3 25 | $818.2M | $583.0M | ||
| Q2 25 | $823.7M | $570.0M | ||
| Q1 25 | $794.4M | $579.0M | ||
| Q4 24 | $774.6M | $650.0M | ||
| Q3 24 | $766.4M | $583.0M | ||
| Q2 24 | $746.6M | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $1.7B | $4.2B | ||
| Q3 25 | $1.7B | $4.3B | ||
| Q2 25 | $1.6B | $4.3B | ||
| Q1 25 | $1.6B | $4.2B | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $1.5B | $4.2B | ||
| Q2 24 | $1.5B | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.37× | ||
| Q3 25 | — | 4.43× | ||
| Q2 25 | — | 4.44× | ||
| Q1 25 | — | 4.29× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | — | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $367.0M |
| Free Cash FlowOCF − Capex | $36.1M | $168.0M |
| FCF MarginFCF / Revenue | 10.0% | 50.3% |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | $63.7M | $152.0M | ||
| Q3 25 | $26.6M | $86.0M | ||
| Q2 25 | $21.1M | $70.0M | ||
| Q1 25 | $11.4M | $59.0M | ||
| Q4 24 | $64.2M | $134.0M | ||
| Q3 24 | $57.3M | $79.0M | ||
| Q2 24 | $50.2M | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | $36.1M | $136.0M | ||
| Q3 25 | $66.0K | $75.0M | ||
| Q2 25 | $-7.2M | $58.0M | ||
| Q1 25 | $-22.6M | $52.0M | ||
| Q4 24 | $29.8M | $109.0M | ||
| Q3 24 | $26.8M | $71.0M | ||
| Q2 24 | $16.7M | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | 10.0% | 40.7% | ||
| Q3 25 | 0.0% | 19.6% | ||
| Q2 25 | -1.7% | 14.6% | ||
| Q1 25 | -6.0% | 16.5% | ||
| Q4 24 | 9.1% | 32.4% | ||
| Q3 24 | 6.7% | 17.9% | ||
| Q2 24 | 3.7% | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 4.8% | ||
| Q3 25 | 7.1% | 2.9% | ||
| Q2 25 | 6.9% | 3.0% | ||
| Q1 25 | 9.0% | 2.2% | ||
| Q4 24 | 10.4% | 7.4% | ||
| Q3 24 | 7.7% | 2.0% | ||
| Q2 24 | 7.4% | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.82× | ||
| Q2 25 | 0.67× | 0.80× | ||
| Q1 25 | 0.49× | 0.97× | ||
| Q4 24 | 182.29× | 1.58× | ||
| Q3 24 | 2.57× | 0.77× | ||
| Q2 24 | 1.29× | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
